The global market for Antibodies Contract Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Antibodies Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antibodies Contract Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Antibodies Contract Manufacturing in SME is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Antibodies Contract Manufacturing include AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma, Lonza, Novasep, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Antibodies Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibodies Contract Manufacturing.

The Antibodies Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibodies Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibodies Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibodies Contract Manufacturing Market Report

Report Metric	Details
Report Name	Antibodies Contract Manufacturing Market
Segment by Type	Monoclonal Antibodies Antibody Fragments Polyclonal Antibodies
Segment by Application	SME Large Enterprise
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma, Lonza, Novasep, Nitto Avecia Pharma Services, Pierre Fabre, Samsung BioLogics, Synthon, Thermo Fisher Scientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibodies Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibodies Contract Manufacturing Market report?

Ans: The main players in the Antibodies Contract Manufacturing Market are AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma, Lonza, Novasep, Nitto Avecia Pharma Services, Pierre Fabre, Samsung BioLogics, Synthon, Thermo Fisher Scientific

What are the Application segmentation covered in the Antibodies Contract Manufacturing Market report?

Ans: The Applications covered in the Antibodies Contract Manufacturing Market report are SME, Large Enterprise

What are the Type segmentation covered in the Antibodies Contract Manufacturing Market report?

Ans: The Types covered in the Antibodies Contract Manufacturing Market report are Monoclonal Antibodies, Antibody Fragments, Polyclonal Antibodies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibodies Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Antibody Fragments

1.2.4 Polyclonal Antibodies

1.3 Market by Application

1.3.1 Global Antibodies Contract Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 SME

1.3.3 Large Enterprise

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibodies Contract Manufacturing Market Perspective (2020-2031)

2.2 Global Antibodies Contract Manufacturing Growth Trends by Region

2.2.1 Global Antibodies Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antibodies Contract Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Antibodies Contract Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Antibodies Contract Manufacturing Market Dynamics

2.3.1 Antibodies Contract Manufacturing Industry Trends

2.3.2 Antibodies Contract Manufacturing Market Drivers

2.3.3 Antibodies Contract Manufacturing Market Challenges

2.3.4 Antibodies Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibodies Contract Manufacturing Players by Revenue

3.1.1 Global Top Antibodies Contract Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Antibodies Contract Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Antibodies Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antibodies Contract Manufacturing Revenue

3.4 Global Antibodies Contract Manufacturing Market Concentration Ratio

3.4.1 Global Antibodies Contract Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibodies Contract Manufacturing Revenue in 2024

3.5 Global Key Players of Antibodies Contract Manufacturing Head office and Area Served

3.6 Global Key Players of Antibodies Contract Manufacturing, Product and Application

3.7 Global Key Players of Antibodies Contract Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antibodies Contract Manufacturing Breakdown Data by Type

4.1 Global Antibodies Contract Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Antibodies Contract Manufacturing Forecasted Market Size by Type (2026-2031)

5 Antibodies Contract Manufacturing Breakdown Data by Application

5.1 Global Antibodies Contract Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Antibodies Contract Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antibodies Contract Manufacturing Market Size (2020-2031)

6.2 North America Antibodies Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antibodies Contract Manufacturing Market Size by Country (2020-2025)

6.4 North America Antibodies Contract Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibodies Contract Manufacturing Market Size (2020-2031)

7.2 Europe Antibodies Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antibodies Contract Manufacturing Market Size by Country (2020-2025)

7.4 Europe Antibodies Contract Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antibodies Contract Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Antibodies Contract Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antibodies Contract Manufacturing Market Size (2020-2031)

9.2 Latin America Antibodies Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antibodies Contract Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Antibodies Contract Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibodies Contract Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Antibodies Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AMRI

11.1.1 AMRI Company Details

11.1.2 AMRI Business Overview

11.1.3 AMRI Antibodies Contract Manufacturing Introduction

11.1.4 AMRI Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.1.5 AMRI Recent Development

11.2 AGC Biologics

11.2.1 AGC Biologics Company Details

11.2.2 AGC Biologics Business Overview

11.2.3 AGC Biologics Antibodies Contract Manufacturing Introduction

11.2.4 AGC Biologics Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.2.5 AGC Biologics Recent Development

11.3 Aldevron

11.3.1 Aldevron Company Details

11.3.2 Aldevron Business Overview

11.3.3 Aldevron Antibodies Contract Manufacturing Introduction

11.3.4 Aldevron Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.3.5 Aldevron Recent Development

11.4 Eurofins CDMO

11.4.1 Eurofins CDMO Company Details

11.4.2 Eurofins CDMO Business Overview

11.4.3 Eurofins CDMO Antibodies Contract Manufacturing Introduction

11.4.4 Eurofins CDMO Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.4.5 Eurofins CDMO Recent Development

11.5 Boehringer Ingelheim BioXcellence

11.5.1 Boehringer Ingelheim BioXcellence Company Details

11.5.2 Boehringer Ingelheim BioXcellence Business Overview

11.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Introduction

11.5.4 Boehringer Ingelheim BioXcellence Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.5.5 Boehringer Ingelheim BioXcellence Recent Development

11.6 FUJIFILM Diosynth Biotechnologies

11.6.1 FUJIFILM Diosynth Biotechnologies Company Details

11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Introduction

11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.7 Emergent BioSolutions

11.7.1 Emergent BioSolutions Company Details

11.7.2 Emergent BioSolutions Business Overview

11.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Introduction

11.7.4 Emergent BioSolutions Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.7.5 Emergent BioSolutions Recent Development

11.8 KBI Biopharma

11.8.1 KBI Biopharma Company Details

11.8.2 KBI Biopharma Business Overview

11.8.3 KBI Biopharma Antibodies Contract Manufacturing Introduction

11.8.4 KBI Biopharma Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.8.5 KBI Biopharma Recent Development

11.9 Lonza

11.9.1 Lonza Company Details

11.9.2 Lonza Business Overview

11.9.3 Lonza Antibodies Contract Manufacturing Introduction

11.9.4 Lonza Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.9.5 Lonza Recent Development

11.10 Novasep

11.10.1 Novasep Company Details

11.10.2 Novasep Business Overview

11.10.3 Novasep Antibodies Contract Manufacturing Introduction

11.10.4 Novasep Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.10.5 Novasep Recent Development

11.11 Nitto Avecia Pharma Services

11.11.1 Nitto Avecia Pharma Services Company Details

11.11.2 Nitto Avecia Pharma Services Business Overview

11.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Introduction

11.11.4 Nitto Avecia Pharma Services Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.11.5 Nitto Avecia Pharma Services Recent Development

11.12 Pierre Fabre

11.12.1 Pierre Fabre Company Details

11.12.2 Pierre Fabre Business Overview

11.12.3 Pierre Fabre Antibodies Contract Manufacturing Introduction

11.12.4 Pierre Fabre Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.12.5 Pierre Fabre Recent Development

11.13 Samsung BioLogics

11.13.1 Samsung BioLogics Company Details

11.13.2 Samsung BioLogics Business Overview

11.13.3 Samsung BioLogics Antibodies Contract Manufacturing Introduction

11.13.4 Samsung BioLogics Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.13.5 Samsung BioLogics Recent Development

11.14 Synthon

11.14.1 Synthon Company Details

11.14.2 Synthon Business Overview

11.14.3 Synthon Antibodies Contract Manufacturing Introduction

11.14.4 Synthon Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.14.5 Synthon Recent Development

11.15 Thermo Fisher Scientific

11.15.1 Thermo Fisher Scientific Company Details

11.15.2 Thermo Fisher Scientific Business Overview

11.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Introduction

11.15.4 Thermo Fisher Scientific Revenue in Antibodies Contract Manufacturing Business (2020-2025)

11.15.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim BioXcellence

FUJIFILM Diosynth Biotechnologies

Emergent Biosolutions

KBI Biopharma

Lonza

Novasep

Nitto Avecia Pharma Services

Pierre Fabre

Samsung Biologics

Synthon

Thermo Fisher Scientific

List of Tables

Table 1. Global Antibodies Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Antibody Fragments

Table 4. Key Players of Polyclonal Antibodies

Table 5. Global Antibodies Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Antibodies Contract Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Antibodies Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Antibodies Contract Manufacturing Market Share by Region (2020-2025)

Table 9. Global Antibodies Contract Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Antibodies Contract Manufacturing Market Share by Region (2026-2031)

Table 11. Antibodies Contract Manufacturing Market Trends

Table 12. Antibodies Contract Manufacturing Market Drivers

Table 13. Antibodies Contract Manufacturing Market Challenges

Table 14. Antibodies Contract Manufacturing Market Restraints

Table 15. Global Antibodies Contract Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Antibodies Contract Manufacturing Market Share by Players (2020-2025)

Table 17. Global Top Antibodies Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies Contract Manufacturing as of 2024)

Table 18. Ranking of Global Top Antibodies Contract Manufacturing Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Antibodies Contract Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Antibodies Contract Manufacturing, Headquarters and Area Served

Table 21. Global Key Players of Antibodies Contract Manufacturing, Product and Application

Table 22. Global Key Players of Antibodies Contract Manufacturing, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Antibodies Contract Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Antibodies Contract Manufacturing Revenue Market Share by Type (2020-2025)

Table 26. Global Antibodies Contract Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Antibodies Contract Manufacturing Revenue Market Share by Type (2026-2031)

Table 28. Global Antibodies Contract Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Antibodies Contract Manufacturing Revenue Market Share by Application (2020-2025)

Table 30. Global Antibodies Contract Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Antibodies Contract Manufacturing Revenue Market Share by Application (2026-2031)

Table 32. North America Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Antibodies Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Antibodies Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Antibodies Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Antibodies Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Antibodies Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Antibodies Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Antibodies Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Antibodies Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 47. AMRI Company Details

Table 48. AMRI Business Overview

Table 49. AMRI Antibodies Contract Manufacturing Product

Table 50. AMRI Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 51. AMRI Recent Development

Table 52. AGC Biologics Company Details

Table 53. AGC Biologics Business Overview

Table 54. AGC Biologics Antibodies Contract Manufacturing Product

Table 55. AGC Biologics Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 56. AGC Biologics Recent Development

Table 57. Aldevron Company Details

Table 58. Aldevron Business Overview

Table 59. Aldevron Antibodies Contract Manufacturing Product

Table 60. Aldevron Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 61. Aldevron Recent Development

Table 62. Eurofins CDMO Company Details

Table 63. Eurofins CDMO Business Overview

Table 64. Eurofins CDMO Antibodies Contract Manufacturing Product

Table 65. Eurofins CDMO Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 66. Eurofins CDMO Recent Development

Table 67. Boehringer Ingelheim BioXcellence Company Details

Table 68. Boehringer Ingelheim BioXcellence Business Overview

Table 69. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product

Table 70. Boehringer Ingelheim BioXcellence Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 71. Boehringer Ingelheim BioXcellence Recent Development

Table 72. FUJIFILM Diosynth Biotechnologies Company Details

Table 73. FUJIFILM Diosynth Biotechnologies Business Overview

Table 74. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product

Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 76. FUJIFILM Diosynth Biotechnologies Recent Development

Table 77. Emergent BioSolutions Company Details

Table 78. Emergent BioSolutions Business Overview

Table 79. Emergent BioSolutions Antibodies Contract Manufacturing Product

Table 80. Emergent BioSolutions Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 81. Emergent BioSolutions Recent Development

Table 82. KBI Biopharma Company Details

Table 83. KBI Biopharma Business Overview

Table 84. KBI Biopharma Antibodies Contract Manufacturing Product

Table 85. KBI Biopharma Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 86. KBI Biopharma Recent Development

Table 87. Lonza Company Details

Table 88. Lonza Business Overview

Table 89. Lonza Antibodies Contract Manufacturing Product

Table 90. Lonza Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 91. Lonza Recent Development

Table 92. Novasep Company Details

Table 93. Novasep Business Overview

Table 94. Novasep Antibodies Contract Manufacturing Product

Table 95. Novasep Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 96. Novasep Recent Development

Table 97. Nitto Avecia Pharma Services Company Details

Table 98. Nitto Avecia Pharma Services Business Overview

Table 99. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product

Table 100. Nitto Avecia Pharma Services Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 101. Nitto Avecia Pharma Services Recent Development

Table 102. Pierre Fabre Company Details

Table 103. Pierre Fabre Business Overview

Table 104. Pierre Fabre Antibodies Contract Manufacturing Product

Table 105. Pierre Fabre Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 106. Pierre Fabre Recent Development

Table 107. Samsung BioLogics Company Details

Table 108. Samsung BioLogics Business Overview

Table 109. Samsung BioLogics Antibodies Contract Manufacturing Product

Table 110. Samsung BioLogics Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 111. Samsung BioLogics Recent Development

Table 112. Synthon Company Details

Table 113. Synthon Business Overview

Table 114. Synthon Antibodies Contract Manufacturing Product

Table 115. Synthon Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 116. Synthon Recent Development

Table 117. Thermo Fisher Scientific Company Details

Table 118. Thermo Fisher Scientific Business Overview

Table 119. Thermo Fisher Scientific Antibodies Contract Manufacturing Product

Table 120. Thermo Fisher Scientific Revenue in Antibodies Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 121. Thermo Fisher Scientific Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Antibodies Contract Manufacturing Picture

Figure 2. Global Antibodies Contract Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antibodies Contract Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. Antibody Fragments Features

Figure 6. Polyclonal Antibodies Features

Figure 7. Global Antibodies Contract Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Antibodies Contract Manufacturing Market Share by Application: 2024 VS 2031

Figure 9. SME Case Studies

Figure 10. Large Enterprise Case Studies

Figure 11. Antibodies Contract Manufacturing Report Years Considered

Figure 12. Global Antibodies Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Antibodies Contract Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Antibodies Contract Manufacturing Market Share by Region: 2024 VS 2031

Figure 15. Global Antibodies Contract Manufacturing Market Share by Players in 2024

Figure 16. Global Top Antibodies Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies Contract Manufacturing as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Antibodies Contract Manufacturing Revenue in 2024

Figure 18. North America Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Antibodies Contract Manufacturing Market Share by Country (2020-2031)

Figure 20. United States Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Antibodies Contract Manufacturing Market Share by Country (2020-2031)

Figure 24. Germany Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Antibodies Contract Manufacturing Market Share by Region (2020-2031)

Figure 32. China Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Antibodies Contract Manufacturing Market Share by Country (2020-2031)

Figure 40. Mexico Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Antibodies Contract Manufacturing Market Share by Country (2020-2031)

Figure 44. Turkey Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Antibodies Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. AMRI Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 48. AGC Biologics Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 49. Aldevron Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 50. Eurofins CDMO Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 51. Boehringer Ingelheim BioXcellence Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 52. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 53. Emergent BioSolutions Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 54. KBI Biopharma Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 55. Lonza Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 56. Novasep Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 57. Nitto Avecia Pharma Services Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 58. Pierre Fabre Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 59. Samsung BioLogics Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 60. Synthon Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Antibodies Contract Manufacturing Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions